Pre-seed · Raised $3.2M · Jul 17, 2026announcement ↗
Sightera Biosciences
BiotechBelgiumsightera-biosciences.com ↗
What they do
Sightera Biosciences is a Belgium-based biotech developing small-molecule medicines with AI trained on patient-derived tissue and drug-response datasets. Its initial pipeline targets oncology, fibrosis, and antibody-drug conjugate payloads, serving patients with treatment-resistant or biomarker-defined diseases and potential pharmaceutical partners.
Hiring outlook
A $3.5 million pre-seed round suggests near-term hiring may focus on founding computational biology and machine-learning engineers, drug-discovery scientists, translational biology specialists, and laboratory or platform operations staff. The company may also add limited business development support for partnerships, while advancing its earliest discovery programs.
Open roles
No open roles on their board right now.